Nowhere is the tension between society-wide policy and individual choice as stark as in the field of public health. Can a committee of experts, informed by scientific evidence and in consultation with stakeholders, realistically make health decisions for a whole population? How might those decisions compare to the choices of individual patients and their physicians?
Fresh from their work collecting evidence to inform screening programmes in the EU, Professors Rebecca Fitzgerald and Harry De Koning discuss the role of evidence in cancer screening policy and how it interfaces with clinical judgement and patient choice.
